ArticleEuropean journal of nuclear medicine and molecular imaging2022

The era of prostate-specific membrane antigen (PSMA)-based theranostics for hepatocellular carcinoma is upcoming: are we ready for it?

Luca Filippi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.